Unknown OBSERVATIONAL NCT01277900

Efficacy and Safety Study of Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) to Treat Type 2 Diabetes Mellitus (ADSMT-1)

Efficacy and Safety Study of LRYGB to Treat Type 2 Diabetes Mellitus

Sponsor: Asia Metabolic Surgery Research Group

Conditions Type 2 Diabetes Mellitus - Poor Control

Interventions Laparoscopic Roux en Y gastric Bypass

Updated 10 times since 2017 Last updated: Jan 14, 2011 Started: Jan 31, 2011 Primary completion: Jan 31, 2012 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01277900, this observational or N/A phase trial focuses on Type 2 Diabetes Mellitus - Poor Control and remains ongoing. Sponsored by Asia Metabolic Surgery Research Group, it has been updated 10 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: PHASE3 → None
Aug 2017 — Apr 2018 [monthly]

Unknown Status PHASE3
Jan 2017 — Aug 2017 [monthly]

Unknown Status PHASE3

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asia Metabolic Surgery Research Group
E-DA Hospital

Data source: Asia Metabolic Surgery Research Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kaohsiung, Taiwan